Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity? [4]

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1540-1541

  García Cortés, Miren ^a   Lucena, M Isabel ^a,b   Andrade, Raul J ^a   Camargo, Raquel ^a   Alcántara, Ramiro ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Clinical Pharmacology Service   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LANSOPRAZOLE; PENICILLIN G; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; CHOLESTASIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; HUMAN; LETTER; LIVER INJURY; LIVER TOXICITY; NARANJO PROBABILITY SCALE; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; SCORING SYSTEM; TOXIC HEPATITIS;

DIAGNOSIS, DIFFERENTIAL; HEPATITIS, TOXIC; HUMANS; PHARMACEUTICAL PREPARATIONS; PROBABILITY;

EID: 4143090284     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E007     Document Type: Letter

References (5)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
2. Andrade RJ, Guilarte J, Salmerón FJ, Lucena MI, Bellot V. Benzylpenicillin-induced prolonged cholestasis (letter). Ann Pharmacother 2001;35:783-4. DOI 10.1345/aph.l0266
3. García-Cortés M, Lucena MI, Andrade RJ, Romero-Gómez M, Fernández MC. Lansoprazole-induced hepatic dysfunction (letter). Ann Pharmacother 2003:37:1731. DOI 10.1345/aph.1C268
4. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.
5. Lucena MI, Camargo R, Andrade RJ, Pérez-Sanchez CJ, Sánchez de la Cuesta F. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001;33:123-30. 1541-1542